Acute gastric dilation associated with the use of semaglutide, a GLP-1 analogue [PMID: 33545249] Laboratory literature summary: Acute gastric dilation associated with the use of semaglutide, a GLP-1 analogue
People experiencing appetite imbalance: GLP-1 therapy gently lowers cravings and promotes a feeling of fullness, allowing patients to make better food choices naturally without restriction or deprivation
If the patient is experiencing gastrointestinal symptoms, EMS personnel should assess for recent increase in dose with their prescribed semaglutide medications, as increasing the dose of semaglutide medications may trigger gastrointestinal symptoms
Alternatively, they may prescribe compounded versions of semaglutide or tirzepatide
No more app-switching." "The AI food scanner is scary accurate
Antioxidants & Redox Signaling, 2012